attention%20deficit_hyperactivity%20disorder
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by the presence of impairing levels of inattention, disorganization and/or hyperactivity-impulsivity.
Symptoms that suggest ADHD include hyperactivity, acting without thinking, inattention/daydreaming, fidgety, restless, excessive talking, aggressive behavior, academic underachievement, disorganized and has difficulty in completing tasks.

Follow Up

  • Initially, monitor on a monthly basis until consistent optimal response is noted
    • Then every 3 months in the 1st year of treatment
  • Subsequent follow-up will depend on patient’s response, adherence to treatment strategy, presence of associated conditions
    • Recommended is at least 2 times a year
  • Monitor treatment outcomes and adverse effects (cardiovascular effects, development of tics or seizures, sexual dysfunction, changes in sleep pattern, worsening behavior, stimulant misuse and diversion) by gathering information from parents, teachers and the child
  • Monitor core symptoms using DSM-IV-TR-based ADHD rating scales (eg Vanderbilt ADHD follow-up scales)
  • Re-evaluate the patient when treatment and management plan does not meet desired outcomes
  • Reassess patient at school-leaving age to check for continuity of care into adulthood 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 01 Mar 2019
Poor diet quality appears to impair mental health, according to a new study.
05 Mar 2019
Obesity and allergic disease increase the risk of mental health problems in adolescents, a recent Korea study has found.
Tristan Manalac, 15 Mar 2019
Neither multinutrient supplementation nor food-related behavioural activation therapy appear to protect against major depressive disorder (MDD) episodes in overweight or obese adults with subsyndromal depressive symptoms, according to a recent study.
11 Apr 2019
Cannabis use disorder appears to exert a beneficial effect on the risk of disorders of gut–brain interaction and inflammatory bowel disease in patients with schizophrenia but not in population controls, a study has found. This finding raises the possibility of new targets for treatment and prevention of digestive organ disorders in schizophrenia.